Cargando…
S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428403/ http://dx.doi.org/10.1097/01.HS9.0000967952.63003.a8 |
| _version_ | 1785090460726853632 |
|---|---|
| author | Rejeski, Kai Greco, Raffaella Onida, Francesco Sánchez-Ortega, Isabel Bonini, Chiara Sureda, Anna Gribben, John Yakoub-Agha, Ibrahim Subklewe, Marion |
| author_facet | Rejeski, Kai Greco, Raffaella Onida, Francesco Sánchez-Ortega, Isabel Bonini, Chiara Sureda, Anna Gribben, John Yakoub-Agha, Ibrahim Subklewe, Marion |
| author_sort | Rejeski, Kai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428403 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284032023-08-17 S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT Rejeski, Kai Greco, Raffaella Onida, Francesco Sánchez-Ortega, Isabel Bonini, Chiara Sureda, Anna Gribben, John Yakoub-Agha, Ibrahim Subklewe, Marion Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428403/ http://dx.doi.org/10.1097/01.HS9.0000967952.63003.a8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Rejeski, Kai Greco, Raffaella Onida, Francesco Sánchez-Ortega, Isabel Bonini, Chiara Sureda, Anna Gribben, John Yakoub-Agha, Ibrahim Subklewe, Marion S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT |
| title | S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT |
| title_full | S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT |
| title_fullStr | S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT |
| title_full_unstemmed | S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT |
| title_short | S260: IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY (ICAHT) FOLLOWING CAR T-CELL THERAPY: INTERNATIONAL SURVEY AND CONSENSUS GUIDELINES ON ITS GRADING, DIAGNOSIS, AND MANAGEMENT ON BEHALF OF EHA AND EBMT |
| title_sort | s260: immune effector cell associated hematotoxicity (icaht) following car t-cell therapy: international survey and consensus guidelines on its grading, diagnosis, and management on behalf of eha and ebmt |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428403/ http://dx.doi.org/10.1097/01.HS9.0000967952.63003.a8 |
| work_keys_str_mv | AT rejeskikai s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT grecoraffaella s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT onidafrancesco s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT sanchezortegaisabel s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT boninichiara s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT suredaanna s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT gribbenjohn s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT yakoubaghaibrahim s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt AT subklewemarion s260immuneeffectorcellassociatedhematotoxicityicahtfollowingcartcelltherapyinternationalsurveyandconsensusguidelinesonitsgradingdiagnosisandmanagementonbehalfofehaandebmt |